Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Viruses and amyloids - a vicious liaison.

Subjects: COVID-19* ; Viruses* ; Virus Diseases*/Virus Diseases*/Virus Diseases*/complications

  • Source: Prion [Prion] 2023 Dec; Vol. 17 (1), pp. 82-104.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101472305 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

SARS-CoV-2 infection as a cause of neurodegeneration.

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; Neurodegenerative Diseases*/Neurodegenerative Diseases*/Neurodegenerative Diseases*/etiology; Humans

  • Source: The Lancet. Neurology [Lancet Neurol] 2024 Jun; Vol. 23 (6), pp. 562-563.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465

Record details

×
Academic Journal

Pentameric C-reactive protein is a better prognostic biomarker and remains elevated for longer than monomeric CRP in hospitalized patients with COVID-19.

  • Authors : Hopkins FR; Division of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Nordgren J

Subjects: COVID-19*; Humans ; C-Reactive Protein

  • Source: Frontiers in immunology [Front Immunol] 2023 Sep 01; Vol. 14, pp. 1259005. Date of Electronic Publication: 2023 Sep 01 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19.

  • Authors : Hopkins FR; Division of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Govender M

Subjects: Monocytes* ; COVID-19*/COVID-19*/COVID-19*/metabolism; Humans

  • Source: Frontiers in immunology [Front Immunol] 2023 Jan 04; Vol. 13, pp. 1082912. Date of Electronic Publication: 2023 Jan 04 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

T cell perturbations persist for at least 6 months following hospitalization for COVID-19.

  • Authors : Govender M; Division of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Hopkins FR

Subjects: COVID-19*; CD8-Positive T-Lymphocytes ; Hospitalization

  • Source: Frontiers in immunology [Front Immunol] 2022 Aug 08; Vol. 13, pp. 931039. Date of Electronic Publication: 2022 Aug 08 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Amyloidogenesis of SARS-CoV-2 Spike Protein.

  • Authors : Nyström S; Department of Physics, Chemistry and Biology, Linköping University, 58183 Linköping, Sweden.; Hammarström P

Subjects: Amyloid*/Amyloid*/Amyloid*/chemistry ; COVID-19*/COVID-19*/COVID-19*/complications ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/chemistry

  • Source: Journal of the American Chemical Society [J Am Chem Soc] 2022 May 25; Vol. 144 (20), pp. 8945-8950. Date of Electronic Publication: 2022 May 17.Publisher: American Chemical Society Country of Publication: United States NLM ID: 7503056 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report.

  • Authors : Nyström K; Department of Infectious Diseases, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Hjorth M

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; Immunologic Deficiency Syndromes*; Antibodies, Neutralizing

  • Source: BMC infectious diseases [BMC Infect Dis] 2022 Apr 11; Vol. 22 (1), pp. 362. Date of Electronic Publication: 2022 Apr 11.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
  • 1-7 of  7 results for ""Nyström S""